Patients whose tumors had a normal BRAF gene showed an overall objective response rate of 61 %. (sciencedaily.com)
The biotech specialist said that its updated phase 2 data in a study of its poziotinib candidate treatment for non-small cell lung cancer resulted in a preliminary confirmed objective response rate and potential progression - free survival benefit in patients with the EGFR Exon 20 Mutant form of the disease. (fool.com)
With nivolumab monotherapy, the observed objective response rate was 23.3 % in the mucosal melanoma group compared with 40.9 % in the cutaneous melanoma group. (cancernetwork.com)